Zobrazeno 1 - 10
of 21
pro vyhledávání: '"L. Dee Nord"'
Publikováno v:
Biochemical Pharmacology. 50:1943-1948
DNA-damaging agents, e.g. Adriamycin ® (ADR), are reported to cause tumor regression by induction of apoptosis. A reduction in the intracellular content of ATP is part of the biochemical cascade of events that ultimately results in programmed death
A novel non-radioactive method for detection of nucleoside analog phosphorylation by 5′-nucleotidase
Publikováno v:
Journal of Biochemical and Biophysical Methods. 25:1-10
Cytosolic 5′-nucleotidase has been implicated in the phosphorylation of certain nucleosides of therapeutic interest. In vitro, IMP and GMP serve as the optimal phosphate donors for this nucleoside phosphotransferase reaction. Existing assays for nu
Autor:
L. Dee Nord, Steven B. Larson, Jack D. Anderson, G. R. Revankar, Roland K. Robins, Howard B. Cottam
Publikováno v:
Journal of Heterocyclic Chemistry. 27:439-453
Synthesis of the pyrazolo[3,4-d]pyrimidin-3-one congeners of guanosine, adenosine and inosine is described. Glycosylation of 3-methoxy-6-methylthio-1H-pyrazolo[3,4-d]pyrimidin-4(5H)-one (13) with 1-O-acetyl-2,3,5-tri-O-benzoyl-D-ribofuranose (16) in
Publikováno v:
Biochemical pharmacology. 51(5)
Treatment with a combination (PMA) of (N-phosphonacetyl)-L-aspartic acid (PALA), methylmercaptopurine riboside (MMPR), and 6-aminonicotinamide (6AN) induced partial regressions of CD8F1 murine mammary tumors and provided for tumor growth inhibition w
Publikováno v:
Cancer investigation. 12(3)
A quadruple drug combination--consisting of a triple-drug combination of N-(phosphonacetyl)-L-aspartate (PALA) + 6-methylmercaptopurine riboside (MMPR) + 6-amino-nicotinamide (6-AN), designed to primarily deplete cellular energy in tumor cells, + Adr
Autor:
Daniel S. Martin, L. Dee Nord
Publikováno v:
Biochemical pharmacology. 42(12)
The effects of 5-fluorouracil (FUra) treatment on thymidine kinase (TKase) activity were examined in vivo in CD8F1 mice bearing first generation CD8F1 mouse mammary tumors. TKase activity was not affected by low dose FUra25 (25 mg/kg), a dose which s
Autor:
Ganapathi R. Revankar, L. Dee Nord, Timothy A. Riley, Donald F. Smee, Roland K. Robins, Randall C. Willis
Publikováno v:
Biochemical Pharmacology. 37:4697-4705
The nucleoside allopurinol riboside-3-thiocarboxamide (APR-TC; 4-(5 H )oxo-1-β- d -ribo-furanosylpyrazolo[3,4,d]pyrimidine-3-thiocarboxamide) demonstrates potent in vitro antiviral activity against various DNA and RNA viruses and cytostatic activity
Autor:
Yogesh S. Sanghvi, Ganapathi R. Revankar, Thomas L. Avery, Timothy S. Breen, Roland K. Robins, Randall C. Willis, L. Dee Nord, Rick Avery Finch
Publikováno v:
Biochemical Pharmacology. 38:3543-3549
The basis for the antitumor activities of the exocyclic amino nucleosides 4-amino-(ARPP) and 4-methoxy-8-(D-ribofuranosylamino)pyrimido[5,4-d]pyrimidine (MRPP) was investigated. The primary target of these nucleosides appeared to be 5-phospho-alpha-D
Autor:
Randall C. Willis, Thomas L. Avery, Yogesh S. Sanghvi, Steven S. Matsumoto, Steven B. Larson, Ganapathi R. Revankar, Roland K. Robins, Donald F. Smee, L. Dee Nord
Publikováno v:
Journal of medicinal chemistry. 32(3)
A novel and direct synthesis of the antiviral and antitumor agent 4-amino-8-(beta-D-ribofuranosylamino)pyrimido[5,4-d]pyrimidine (ARPP, 8) and its alpha-anomer (11) has been developed. Treatment of 2,4,6,8-tetrachloropyrimido[5,4-d]pyrimidine (1) wit
Autor:
Roland K. Robins, Emmanuel Ojo-Amaize, Zahra Parandoosh, Howard B. Cottam, Steven S. Matsumoto, Ganapathi R. Revankar, Donald F. Smee, James M. Fujitaki, Randall C. Willis, Boanerges Rubalcava, L. Dee Nord, Weldon B. Jolley
Publikováno v:
Advances in enzyme regulation. 29
Unlike conventional enzymes, receptors that activate G proteins do not catalyze the direct formation or cleavage of covalent bonds but act instead as a catalyst for the exchange of GTP vs GDP, which results in major conformational changes in the alph